Targeted therapies in advanced biliary tract cancers—a narrative review
Chinese Clinical Oncology · 2023-04 · 12 (2) · 14-14
DOI: 10.21037/cco-22-93 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chinese Clinical Oncology, 2023-04. Verfasst von Michael LaPelusa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
LaPelusa, M., Heumann, T., Goff, L., & Agarwal, R. (2023). Targeted therapies in advanced biliary tract cancers—a narrative review. Chinese Clinical Oncology, 12(2), 14-14. https://doi.org/10.21037/cco-22-93
Vancouver
LaPelusa M, Heumann T, Goff L, Agarwal R. Targeted therapies in advanced biliary tract cancers—a narrative review. Chinese Clinical Oncology. 2023;12(2):14-14. doi:10.21037/cco-22-93
BibTeX
@article{LaPelusa2023,
author = {LaPelusa, Michael and Heumann, Thatcher and Goff, Laura and Agarwal, Rajiv},
title = {Targeted therapies in advanced biliary tract cancers—a narrative review},
journal = {Chinese Clinical Oncology},
year = {2023},
volume = {12},
number = {2},
pages = {14--14},
doi = {10.21037/cco-22-93}
}
EUVIMED